Scientific Review
Our Scientific Team
Pure Peptides content is produced and reviewed by a qualified scientific editorial team operating under our strict research-use-only framework.

Dr. Martina Rossi
Scientific Contributor and Reviewer
Dr. Martina Rossi holds a PhD from Université Grenoble Alpes, where her doctoral research examined the vascular functions of Bone Morphogenetic Proteins in knockout mouse models. Her published work spans cell and molecular biology, vascular biology, and gene therapy, with peer-reviewed contributions appearing in journals including Cardiovascular Research, Scientific Reports, and Brain Sciences. Dr. Rossi serves as Scientific Contributor for the Pure Peptides research content program, researching and drafting product descriptions and inserting verified PubMed citations into the research context section of each description; all content she produces is checked for scientific accuracy by our editorial review process before publication.
Selected Publications
- 1Rossi M et al. (2023). Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice. Scientific Reports 13, 5976. DOI: 10.1038/s41598-023-32633-1
- 2Bouvard C, Rossi M et al. (2022). Different cardiovascular and pulmonary phenotypes for single and double knockout mice deficient in BMP9 and BMP10. Cardiovascular Research 118(7), 1805-1820. DOI: 10.1093/cvr/cvab187
- 3Rossi M. (2023). Advancements and Challenges in Gene Therapy Approaches for Sickle Cell Disease. SciRevs Biology 2, 18-24. DOI: 10.57098/SciRevs.Biology.2.3.3
- 4Rossi M. (2023). Acknowledging the Approval of World-First Gene Therapy for Sickle Cell Disease Through CRISPR-Mediated Gene Editing. Science Reviews Biology 2(4), 15-18. DOI: 10.57098/SciRevs.Biology.2.4.3
- 5Costanza A, Rossi M et al. (2024). Reactive Astrocytosis - A Potential Contributor to Increased Suicide in Long COVID-19 Patients. Brain Sciences 14, 973. DOI: 10.3390/brainsci14100973

Dr. Tharindunee Jayakody
Scientific Contributor and Reviewer
Dr Jayakody is a molecular pharmacologist with over 15 years of experience in translating complex research into clear, evidence-based explanations, with expertise on peptide therapeutics and other emerging compounds, particularly in delineating the mechanisms of action of therapeutics. As a contributor to research-focused platforms, Dr Jayakody aims to give scientifically literate readers a balanced view of what current data can and cannot support, helping them understand how promising findings in the lab translate, or sometimes fail to translate, into real-world applications.
Selected Publications
- 1Jayakody T et al. (2024). Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor. Science Signaling 17(823), eabl5880. DOI: 10.1126/scisignal.abl5880
- 2Jayakody T, Budagoda DK, Mendis K et al. (2025). Biased agonism in peptide-GPCRs: A structural perspective. Pharmacology & Therapeutics 269, 108806. DOI: 10.1016/j.pharmthera.2025.108806
- 3Mendis K et al., Jayakody T. (2025). Neuropharmacology and the applications of herbal extracts found within Sri Lankan traditional anxiety remedies. Phytomedicine Plus 5(3), 100794. DOI: 10.1016/j.phyplu.2025.100794
Education
Education Authors
Each Education article is written by a named scientist, who checks its claims against the sources listed under it and approves the text before it is published.

Dr. Sufia Ul Haque
Chemist and scientific writer
PhD in chemistry, Aligarh Muslim University
Dr. Sufia Ul Haque is a chemist and scientific writer. She holds a PhD in chemistry from Aligarh Muslim University and carried out postdoctoral research in organic and natural-product synthesis in the United States, where her work included multistep synthesis, purification and chromatography. She has published in journals including Biosensors and Bioelectronics, the Journal of Power Sources and Scientific Reports, and reviews for several international journals. She writes about chemistry for readers without a scientific background.
Disclosure: No conflicts of interest declared.
Articles

Julia Piccoli, PhD
Associate R&D Director, Kemin Industries LATAM
PhD in Biotechnology
Dr. Julia Piccoli is the Associate R&D Director for Latin America at Kemin Industries in Brazil, where she leads innovation and technical strategy initiatives across the animal nutrition market. She holds a bachelor's degree in chemistry and earned both her M.Sc. and Ph.D. in Biotechnology. With more than 14 years of experience in academia and industry, her work has focused on peptides, biotechnology, food preservation, enzymes, and applied innovation for both pharmaceutical and animal nutrition. Julia collaborates closely with commercial, regulatory, and technical teams to translate scientific research into practical solutions that create value for customers and the industry.
Disclosure: Employed by Kemin do Brasil. The opinions expressed are her own and do not necessarily reflect those of her employer. No conflicts of interest related to the information presented are declared.
Articles
Our Scientific Review Process
Every product description and article published on Pure Peptides is researched, reviewed and approved by our scientific team before publication. All content is checked for scientific accuracy, compliance with our research-use-only framework, and appropriate citation of published preclinical research. No content goes live without scientific sign-off.
Our Content Standards
Pure Peptides publishes scientific reference content about research compounds for informational purposes only. No health claims or therapeutic claims appear anywhere on this site. Laboratory handling, storage and reconstitution information is provided for in-vitro research safety and planning only. All compounds are sold strictly for in vitro research purposes only and are not intended for human consumption.
For questions about our editorial standards, please get in touch
